Breast Carcinoma That is Estrogen Receptor, Progesterone Receptor, and Her2 Negative
1 clinical trials · Condition
◉ Watch Breast Carcinoma That is Estrogen Receptor, Progesterone Receptor, and Her2 Negative
| Record | Firm | Date |
|---|---|---|
| A Study of XmAb®23104 in Subjects With Selected Advanced Solid Tumors (DUET-3) (NCT03752398) | Xencor, Inc. | 2019-05-01 |
Track Breast Carcinoma That is Estrogen Receptor, Progesterone Receptor, and Her2 Negative automatically
Every clearance here is in the API, with alerts when new ones post.